FDA Category 2 Update: The 5 Peptides Still Facing Heavy Review As excitement builds around peptides potentially moving off the FDA Category 2 list, it's important to understand one key reality: Not Upcoming FDA APPROVALS : March April 2026 . : r biotech_stocks FDA Announces Change in Status of 12 Peptides SSRP Institute FDA approval awaited this month . : r biotech_stocks FDA Alerts: Ophthalmology Drug and Device Approvals Ophthalmology Advisor